Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kewaunee Scientific (KEQU) EPS (Weighted Average and Diluted) (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.82 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 18.81% year-over-year to $0.82; the TTM value through Oct 2025 reached $3.94, down 37.85%, while the annual FY2025 figure was $3.83, 39.97% down from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.82 in Q4 2025 per KEQU's latest filing, down from $1.04 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $3.74 in Q2 2024 and bottomed at -$1.11 in Q4 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.45, with a median of $0.41 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 1666.67% in 2022, then skyrocketed 1133.33% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$1.11 in 2021, then surged by 91.89% to -$0.09 in 2022, then surged by 1133.33% to $0.93 in 2023, then rose by 8.6% to $1.01 in 2024, then decreased by 18.81% to $0.82 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.82 in Q4 2025, $1.04 in Q3 2025, and $1.63 in Q2 2025.